Dr Jeff Porter Sharman, MD | |
520 Country Club Pkwy, Eugene, OR 97401-6036 | |
(541) 683-5001 | |
(541) 683-1422 |
Full Name | Dr Jeff Porter Sharman |
---|---|
Gender | Male |
Speciality | Hematology/oncology |
Experience | 23 Years |
Location | 520 Country Club Pkwy, Eugene, Oregon |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1659596179 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RH0003X | Internal Medicine - Hematology & Oncology | A87148 (California) | Secondary |
207RX0202X | Internal Medicine - Medical Oncology | MD28267 (Oregon) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Cascade Health Solutions | Eugene, OR | Hospice |
Sacred Heart Medical Center - Riverbend | Springfield, OR | Hospital |
Bay Area Hospital | Coos bay, OR | Hospital |
Peace Harbor Medical Center | Florence, OR | Hospital |
Good Samaritan Regional Medical Center | Corvallis, OR | Hospital |
Samaritan Albany General Hospital | Albany, OR | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Oncology Associates Of Oregon P C | 7214924406 | 34 |
News Archive
In a subset of patients suffering heart attack, adding stents to clot-busting medical therapy after the optimal treatment window ends isn't justified, say researchers from Duke University Medical Center.
A new molecular test for tuberculosis can diagnose the disease and detect a drug-resistant form of it in less than two hours and more accurately than current tests, according to the findings of a study published online in the New England Journal of Medicine on Wednesday, Reuters reports (Kelland, 9/1).
High eye pressure is the leading risk factor for glaucoma, and is the only modifiable one. If glaucoma is untreated, vision loss may continue, leading to blindness in some individuals.
Newly discovered genetic switches that increase lifespan and boost fitness in worms are also linked to increased lifespan in mammals, offering hope that drugs to flip these switches could improve human metabolic function and increase longevity.
› Verified 1 days ago
Entity Name | Oncology Associates Of Oregon P C |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1013989854 PECOS PAC ID: 7214924406 Enrollment ID: O20040429000103 |
News Archive
In a subset of patients suffering heart attack, adding stents to clot-busting medical therapy after the optimal treatment window ends isn't justified, say researchers from Duke University Medical Center.
A new molecular test for tuberculosis can diagnose the disease and detect a drug-resistant form of it in less than two hours and more accurately than current tests, according to the findings of a study published online in the New England Journal of Medicine on Wednesday, Reuters reports (Kelland, 9/1).
High eye pressure is the leading risk factor for glaucoma, and is the only modifiable one. If glaucoma is untreated, vision loss may continue, leading to blindness in some individuals.
Newly discovered genetic switches that increase lifespan and boost fitness in worms are also linked to increased lifespan in mammals, offering hope that drugs to flip these switches could improve human metabolic function and increase longevity.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Jeff Porter Sharman, MD 520 Country Club Pkwy, Eugene, OR 97401-6036 Ph: (541) 683-5001 | Dr Jeff Porter Sharman, MD 520 Country Club Pkwy, Eugene, OR 97401-6036 Ph: (541) 683-5001 |
News Archive
In a subset of patients suffering heart attack, adding stents to clot-busting medical therapy after the optimal treatment window ends isn't justified, say researchers from Duke University Medical Center.
A new molecular test for tuberculosis can diagnose the disease and detect a drug-resistant form of it in less than two hours and more accurately than current tests, according to the findings of a study published online in the New England Journal of Medicine on Wednesday, Reuters reports (Kelland, 9/1).
High eye pressure is the leading risk factor for glaucoma, and is the only modifiable one. If glaucoma is untreated, vision loss may continue, leading to blindness in some individuals.
Newly discovered genetic switches that increase lifespan and boost fitness in worms are also linked to increased lifespan in mammals, offering hope that drugs to flip these switches could improve human metabolic function and increase longevity.
› Verified 1 days ago
Richard Romm, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 677 E 12th Ave, Suite N400, Eugene, OR 97401 Phone: 541-484-4332 Fax: 541-302-0786 | |
William E Wilkins Jr., M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 330 S Garden Way Ste 350, Eugene, OR 97401 Phone: 541-746-6816 | |
Dr. Norman Paul Hudson, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2479 Oakmont Way, Eugene, OR 97401 Phone: 541-484-0195 Fax: 541-343-6317 | |
Kirk Douglas Jacobson, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1488 Oak St, Eugene, OR 97401 Phone: 541-431-0000 Fax: 541-344-6176 | |
Matthew B. Walter, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3125 Chad Dr Ste 100, Eugene, OR 97408 Phone: 541-687-1712 Fax: 541-687-7943 | |
Sarah Cassell, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 132 E Broadway Ste 830, Eugene, OR 97401 Phone: 541-687-0816 Fax: 541-687-1086 | |
Dr. Klarissa N Beller, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1200 Hilyard St Ste 520a, Eugene, OR 97401 Phone: 541-687-6041 Fax: 541-687-6009 |